Emily Delosreyes
Neurology with Special Qualifications in Child Neurology · Columbus, OHNPI 1871595827
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (38.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Biomarin Pharmaceutical Inc. accounts for 77.9% of it on its own, with 6 other manufacturers making up the rest. Among neurology with special qualifications in child neurology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 104 payments — averaging $756.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$61K
- Amicus Therapeutics, Inc.$15K
- Zogenix Inc.$1K
- UCB, Inc.$273
- Biocodex, Inc.$240
- Greenwich Biosciences, Inc.$126
- plus $17 from 1 others
Across 206 payments — averaging $23,362 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amicus Therapeutics, Inc.$2.6M
- Biomarin Pharmaceutical Inc.$2.2M
What the payments were for
- Consulting fees$30,10938%
- Speaking & faculty fees$19,43425%
- Travel & lodging$18,56024%
- Food & beverage$3,4994%
- Education$7,0249%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 84 | $61,250 |
| Amicus Therapeutics, Inc. | 10 | $15,320 |
| Zogenix Inc. | 1 | $1,400 |
| UCB, Inc. | 4 | $273 |
| Biocodex, Inc. | 3 | $240 |
| Greenwich Biosciences, Inc. | 1 | $126 |
| Catalyst Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$78,627 in reported general payments places this provider in the 90th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.
See all neurology with special qualifications in child neurology providers in Ohio →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LamictalLamotrigine | 11 | $16,964 |
| Clobazam | 24 | $1,987 |
| Lacosamide | 11 | $1,837 |
| Levetiracetam | 15 | $1,538 |
| Gabapentin | 35 | $755 |
| Lamotrigine | 14 | $601 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 16 | $386 |
| Baclofen | 12 | $154 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Columbus
- Anne ConnollyColumbus$154K
- Samiah Al-ZaidyColumbus$70K
- Ann PakalnisColumbus$56K
- Diana Bharucha-GoebelColumbus$40K
- Megan WaldropColumbus$40K
- Sylvia AwadallaColumbus$39K
- Kevin FlaniganColumbus$24K
- Anup PatelColumbus$14K
- Kelsey PoissonColumbus$13K
- Melissa ChungColumbus$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.